Article Text

Download PDFPDF

Effectiveness and cost-effectiveness of Self-Help Plus (SH+) for preventing mental disorders in refugees and asylum seekers in Europe and Turkey: study protocols for two randomised controlled trials
  1. Marianna Purgato1,2,
  2. Kenneth Carswell3,
  3. Ceren Acarturk4,
  4. Teresa Au3,
  5. Sena Akbai5,
  6. Minna Anttila6,
  7. Josef Baumgartner7,
  8. Della Bailey8,
  9. Massimo Biondi9,
  10. Martha Bird10,
  11. Rachel Churchill11,
  12. Sevde Eskici5,
  13. Louise Juul Hansen10,
  14. Paul Heron12,
  15. Zeynep Ilkkursun5,
  16. Reinhold Kilian13,
  17. Markus Koesters2,13,
  18. Tella Lantta14,
  19. Michela Nosè1,2,
  20. Giovanni Ostuzzi1,2,
  21. Davide Papola1,2,
  22. Mariana Popa15,
  23. Marit Sijbrandij16,
  24. Lorenzo Tarsitani9,
  25. Federico Tedeschi1,
  26. Giulia Turrini1,2,
  27. Ersin Uygun17,
  28. Maritta Anneli Välimäki6,18,
  29. Johannes Wancata19,
  30. Ross White15,
  31. Elisa Zanini1,
  32. Pim Cuijpers20,
  33. Corrado Barbui1,2,
  34. Mark Van Ommeren21
  1. 1Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy
  2. 2Cochrane Global Mental Health, Verona, Italy
  3. 3Department of Mental Health & Substance Abuse, World Health Organisation, Geneve, Switzerland
  4. 4Istanbul Sehir Universitesi, Istanbul, Turkey
  5. 5Department of Psychology, Istanbul Sehir Universitesi, Istanbul, Turkey
  6. 6Department of Nursing Science, University of Turku, Turku, Finland
  7. 7Department of Psychiatry and Psychotherapy, Medical University of Vienna, Wien, Austria
  8. 8Health Sciences, University of York, York, UK
  9. 9Department of Human Neurosciences, University of Rome La Sapienza, Roma, Lazio, Italy
  10. 10IFRC Reference Centre for Psychosocial Support, Danish Red Cross, Copenhagen, Denmark
  11. 11University of York, York, UK
  12. 12Department of Health Sciences, University of York, York, UK
  13. 13Department of Psychiatry II, Ulm University, Ulm, Germany
  14. 14Department of Nursing Science, Turun Yliopisto, Turku, Finland
  15. 15Institute of Life and Human Sciences, University of Liverpool, Liverpool, UK
  16. 16Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
  17. 17Trauma and Disaster Mental Health, Istanbul Bilgi Universitesi, Istanbul, Turkey
  18. 18School of Nursing, Hong Kong Polytechnic University, Kowloon, Hong Kong
  19. 19Department of Psychiatry and Psychotherapy, Division of Social Psychiatry, Medical University of Vienna, Vienna, Austria
  20. 20Department of Clinical Psychology, VU University Amsterdam, Amsterdam, The Netherlands
  21. 21Department of Mental Health and Substance Dependence, World Health Organisation, Geneva, Switzerland
  1. Correspondence to Dr Marianna Purgato; marianna.purgato{at}univr.it

Abstract

Introduction This article describes two randomised controlled trials that will evaluate the effectiveness and cost-effectiveness of Self-Help Plus (SH+), a group self-help intervention developed by the WHO to reduce distress. In these trials SH+ is being tested as a preventative intervention to lower the incidence of mental disorders in asylum seekers and refugees with psychological distress resettled in Europe and Turkey.

Methods and analysis Two prospective, multicentre, randomised, rater-blinded, parallel-group studies will follow participants over a period of 12 months. One trial will be conducted in Europe and one in Turkey. In each trial, 600 asylum seekers and refugees screening positive on the General Health Questionnaire (≥3), but without a formal diagnosis of any mental disorders according to the Mini International Neuropsychiatric Interview, will be randomly allocated to SH+or to enhanced treatment-as-usual. The primary outcome will be a lower incidence of mental disorders at 6 month follow-up. Secondary outcomes will include the evaluation of psychological symptoms, functioning, well-being, treatment acceptability and indicators of intervention cost-effectiveness.

Ethics and dissemination The two trials received ethical clearance from the local Ethics Committees of the participating sites (seven sites), as well as from the WHO Ethics Committee. All participants will provide informed consent before screening and before study inclusion (a two-step procedure). The results of the trials will be disseminated in agreement with a dissemination plan that includes publication(s) in peer-reviewed journals and presentations at relevant national and international conferences and meetings.

Trials registration numbers NCT03571347, NCT03587896.

  • randomized controlled trials
  • psychosocial interventions
  • asylum seekers
  • refugees
  • global mental health

This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.

Statistics from Altmetric.com

Footnotes

  • Contributors The study was conceived and designed by MvO and CB. MP and CB drafted the manuscript. CA, TA, KC, MN, GO, FT, GT and MvO contributed to the study design and commenting/editing the manuscript drafts. SA, MA, JB, DB, MB, MBirth, RC, SE, LJH, PH, ZI, RK, MK, TL, DP, MP, MS, LT, EU, MV, JW, RW, EZ, PC provided comments/revisions to the manuscript drafts.

  • Funding This work is supported by the European Commission, grant agreement n. 779255 “RE-DEFINE: Refugee Emergency: DEFining and Implementing Novel Evidence-based psychosocial interventions”. The funder had no role in study design, and will have no role in data management, analysis, interpretation of data, writing the report and the decision to submit the report for publication nor ultimate authority over any of the listed activities. EU will have the possibility to audit the financial project management, while for the scientific part deliverables and milestones are being provided to the EU according to the grant agreement.

  • Disclaimer The authors alone are responsible for the views expressed in this article and they do not necessarily represent the views, decisions or policies of the institutions with which they are affiliated.

  • Competing interests None declared.

  • Ethics approval The study protocols have been approved by: Local Ethics Committees and WHO ERC: Verona: Comitato Etico per la Sperimentazione Clinica delle province di Verona e Rovigo; Approval ID 1682CESC Ulm: Furdie Ethikkommission der Universitat Ulm; Approval ID 93/18 Vienna: Ethik Kommission, University of Vienna; Approval ID 1199/2018 Liverpool: Central University Research Ethics Committee B; Approval ID 3198 York: Health Sciences Research Governance Committee; Approval 16-03-2018 Turku: Varsinais-Suomen sairaanhoitopiirin kuntayhtymä Eettinen toimikunta; Approval ID 19/1801/2018 Istanbul: Istanbul Sehir Universitesi; Approval 8-03-2018 WHO: WHO ERC Ethics Committee Approval ID: ERC.0003021

  • Provenance and peer review Not commissioned; peer reviewed for ethical and funding approval prior to submission.

  • Patient consent for publication Not required.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.